GRAIL to Announce Second Quarter 2024 Financial Results
MENLO PARK, Calif., July 31, 2024 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer...
MENLO PARK, Calif., July 31, 2024 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer...
SEATTLE, July 31, 2024 /PRNewswire/ -- TwinStrand Biosciences today announced an agreement with Exact Sciences (Nasdaq: EXAS), a leading provider...
As well as Diabetes, Multiple Sclerosis and Other Diseases ALLEN, TX / ACCESSWIRE / July 31, 2024 / Enzolytics, Inc....
New patent issued for core rare disease target indication for crofelemerJaguar has approximately 200 patents issued and pendingJaguar is supporting...
Halifax, Nova Scotia--(Newsfile Corp. - July 31, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") is...
Dublin, Ireland--(Newsfile Corp. - July 31, 2024) - Cosmo Intelligent Medical Devices (Cosmo IMD), a division of Cosmo Pharmaceuticals N.V....
NEW YORK, July 30, 2024 /PRNewswire/ -- The global 3D printing medical devices market size is estimated to grow by...
NEW YORK, July 30, 2024 /PRNewswire/ -- The global telehealth market size is estimated to grow by USD 368.7 billion from...
NEW YORK, July 30, 2024 /PRNewswire/ -- The global digital health market size is estimated to grow by USD 1.06...
Inaugural Igniting Innovation research announcement is providing more than $7 million in funding to advance cancer research through space-based R&D...
Noze is the first-ever Canadian company to receive investment funding from the Bill & Melinda Gates Foundation. MONTREAL, July 30,...
Former Veeva and ERT clinical trial technology executive will drive strategy towards a complete, tech-enabled biospecimen lifecycle solution RICHMOND, Va.,...
BURLINGTON, N.C., and FREMONT, Calif., July 29, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive...
Dr. Abby C. Collier will take over from Leah Lariviere as Executive Director, effective August 1, 2024Vancouver, British Columbia--(Newsfile Corp....
Data partnership initiative expands access to critical healthcare data in ophthalmology, urology and neurologySAN FRANCISCO, July 30, 2024 (GLOBE NEWSWIRE)...
GAITHERSBURG, Md., July 30, 2024 (GLOBE NEWSWIRE) -- Today, Georgiamune Inc., a privately held, clinical-stage biotechnology company, announced that the first...
Nascent CEO-Sean Carrick-Discusses Phase I Results and Forward Clinical Strategy while laying out Investment Opportunity of the Company NORTH PALM...
Strategic in-license from Cortice Bioscience is highly synergistic with the ongoing potentially pivotal Berubicin program and demonstrates further commitment to...
NORWOOD, Mass., July 30, 2024 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), today announced...
SNK01, a cryopreserved autologous non-genetically modified NK cell product, is able to effectively reduce α-synuclein (α-syn) protein levels in the...